CPRIT Releases Two RFAs for Product Development Research

CPRIT Product Development Programs 

Capture

  1. Company Relocation Product Development Awards

Product Development Program Priorities

 Funding projects at Texas companies and relocating companies that are most likely to bring important products to the market

 Providing funding that promotes the translation of research at Texas institutions into new companies able to compete in the marketplace

 Identifying and funding projects to develop tools and technologies of special relevance to cancer research, treatment, and prevention

EXECUTIVE SUMMARY

CPRIT will foster the creation of high-quality new jobs in Texas by providing financial support for a wide variety of projects relevant to cancer. The award mechanism described in this RFA is designed to encourage the relocation of existing oncology-focused companies or a substantial portion of their business to Texas. CPRIT expects outcomes of supported activities to directly and indirectly benefit subsequent cancer research efforts, cancer public health policy, or the continuum of cancer care—from prevention to treatment and cure. To fulfill this vision, applications may address any product development topic or issue related to cancer biology, causation, prevention, detection or screening, treatment, or cure. The overall goal of this award program is to improve outcomes of patients with cancer by increasing the availability of Food and Drug Administration (FDA)–approved therapeutic interventions with a primary focus on Texas-centric programs.

MECHANISM OF SUPPORT

The goal of the Company Relocation Product Development Award is to finance the research and development of innovative products, services, and infrastructure with significant potential impact on patient care. These investments will provide companies or limited partnerships that are willing to relocate all or a substantial portion of their business to Texas with the opportunity to further the development of new products for the diagnosis, treatment, supportive care, or prevention of cancer; to establish infrastructure that is critical to the development of a robust industry; or to fill a treatment, industry, or research gap. This award mechanism will support companies that intend to undertake product research and development in Texas with a strong presence of Texas-based employees.

OBJECTIVES

The state of Texas seeks to attract industry partners in the field of cancer care to advance economic development and cancer care efforts in the state. The goal of this award mechanism is to recruit to Texas companies with proven management teams who are focused on exceptional product opportunities to improve cancer care. These companies must presently be domiciled outside of Texas and have sufficient personnel to operate the Texas-based research and/or development activities of the company and, along with appropriate management, must be willing to relocate to or be hired and remain in Texas for a specified period after funding. Eligible products or services include—but are not limited to—therapeutics (eg, small molecules and biologics), diagnostics, devices, and potential breakthrough technologies, including software and research discovery techniques. Eligible stages of research development include translational research, proof-of-concept studies, preclinical studies, and phase 1 or phase 2 clinical trials. By exception, phase 3 clinical trials and later-stage product development projects will be considered where circumstances warrant CPRIT investment.

CPRIT’s objectives and program priorities are established by its Oversight Committee. Consistent with the above, these priorities include, “funding projects at Texas companies and relocating companies that are most likely to bring important products to the market.” A full description of CPRIT’s program priorities may be found at http://www.cprit.state.tx.us/about-cprit/reports.

2. Texas Company Product Development Awards

2.1. Product Development Program Priorities

Legislation from the 83rd Texas Legislature requires that CPRIT’s Oversight Committee establish program priorities on an annual basis. The priorities are intended to provide transparency in how the Oversight Committee directs the orientation of the agency’s funding portfolio. The Product Development Program’s principles and priorities will also guide CPRIT staff and the Product Development Review Council on the development and issuance of program-specific Requests for Applications (RFAs) and the evaluation of applications submitted in response to those RFAs. Established Principles:

 Moving forward the development of commercial products to diagnose and treat cancer and improve the lives of patients with cancer

 Creation of good, high-paying jobs for Texans CPRIT RFA C-16-2-TXCO Texas Company Product Development Awards p.6/28 (Rev 12/28/15)

 Sound financial return on the monies invested

 Development of the Texas high-tech life sciences business environment

EXECUTIVE SUMMARY

CPRIT will foster cancer research as well as product and service development in Texas by providing financial support for a wide variety of projects relevant to cancer. This RFA solicits applications for the research and development of innovative products addressing critically important needs related to diagnosis, prevention, and/or treatment of cancer and the product development infrastructure needed to support these efforts. CPRIT encourages applicants who seek to apply or develop state-of-the-art products, services (eg, contract research organization services), technologies, tools, and/or resources for cancer research, prevention, or treatment. CPRIT expects outcomes of supported activities to directly and indirectly benefit subsequent cancer research efforts, cancer public health policy, or the continuum of cancer care—from prevention to treatment and cure. To fulfill this vision, applications may address any topic or issue related to cancer biology, causation, prevention, detection or screening, treatment, or cure.

MECHANISM OF SUPPORT

The goal of the Texas Company Product Development Award is to finance the research and development of innovative products, services, and infrastructure with significant potential impact on patient care. These investments will provide companies or limited partnerships located and headquartered in Texas with the opportunity to further the research and development of new products for the diagnosis, treatment, supportive care, or prevention of cancer; to establish infrastructure that is critical to the development of a robust industry; or to fill a treatment, industry, or research gap. This award is intended to support companies that will be staffed with a majority of Texas-based employees, including C-level executives.

 OBJECTIVES

The long-term objective of this award is to support commercially oriented therapeutic and medical technology products, diagnostic- or treatment-oriented information technology products, diagnostics, tools, services, and infrastructure projects. Common to all applications under this RFA (with the exception of infrastructure applications) should be the intent to further the research and development of products that would eventually be approved for marketing for the diagnosis, prevention, and/or treatment of cancer. Eligible products or services include—but are not limited to—therapeutics (eg, small molecules and biologics), diagnostics, devices, and potential breakthrough technologies, including software and research discovery techniques. Eligible stages of research and development include translational research, proof-of-concept studies, preclinical studies, and phase 1 or phase 2 clinical trials. By exception, phase 3 clinical trials and later-stage product development projects will be considered where circumstances warrant CPRIT investment.

CPRIT’s objectives and program priorities are established by its Oversight Committee. Consistent with the above, these priorities include, “funding projects at Texas companies and relocating companies that are most likely to bring important products to the market.” A full description of CPRIT’s program priorities may be found at http://www.cprit.state.tx.us/about-cprit/reports/.

CPRIT Releases Request for Applications (RFAs) for Cancer Prevention

Cancer Prevention and Research Institute of Texas CPRIT Logo_Final

Review Cycle Award Mechanism
Request for Application
RFA Release Application Receipt Application Review Award Notification
Financial Year 2016 – Cycle 2 Cancer Prevention Promotion and Navigation to Clinical Services

This award mechanism seeks to fund projects that deliver public education and outreach and navigation to cancer screening and preventive services. The proposed project must assist participants in obtaining prevention interventions being promoted by providing navigation services.

Award: Maximum of $400,000; Maximum duration of 36 months.

Sep 10, 2015 Sep 24, 2015-Jan 7, 2016 Mar 2016 May 2016
Financial Year 2016 – Cycle 2 Competitive Continuation/Expansion – Evidence-Based Cancer Prevention Services

This award mechanism seeks to fund continuation or expansion of currently or previously funded projects that have demonstrated exemplary success, as evidenced by project results, outcomes and impact of the currently or previously funded project. The proposed project should closely follow the intent and core elements of the currently or previously funded project.

Award: Maximum of $1.5M; Maximum duration of 36 months.

Sep 10, 2015 Sep 24, 2015-Jan 7, 2016 Mar 2016 May 2016
Financial Year 2016 – Cycle 2 Dissemination of CPRIT-Funded Cancer Control Interventions

This award mechanism seeks to fund projects that will facilitate the dissemination and implementation of successful CPRIT-funded, evidence-based cancer prevention and control interventions across Texas. The proposed project should be in a position to develop one or more “products” based on the results of the CPRIT-funded intervention. The proposed project should also identify and assist others to prepare to implement the intervention and/or prepare for grant funding.

Award: Maximum of $300,000; Maximum duration of 24 months.

Sep 10, 2015 Sep 24, 2015-Jan 7, 2016 Mar 2016 May 2016
Financial Year 2016 – Cycle 2 Evidence-Based Cancer Prevention Services

Evidence-Based Cancer Prevention Services – This award mechanism seeks to fund projects that will deliver evidence-based cancer prevention and control clinical services. Priority will be given to projects that propose to address CPRIT areas of emphasis and serve areas of the state not well addressed by current CPRIT funded projects.

Award: Maximum of $1.5M; Maximum duration of 36 months.

Sep 10, 2015 Sep 24, 2015-Jan 7, 2016 Mar 2016 May 2016
Financial Year 2016 – Cycle 2 Evidence-Based Cancer Prevention Services – See, Test & Treat® Program

This award mechanism seeks to fund projects that follow the CAP Foundation’s See, Test & Treat model to offer effective and efficient evidence-based prevention and screening services, with same day results provided to participants on Pap tests and on mammograms; provide information on prevention, risk reduction, healthy lifestyles and early detection to the public; navigate participants to further diagnostic testing and follow-up; and navigate participants to treatment as needed.

Award: Maximum of $25K; Maximum duration of 12 months.

Sep 10, 2015 Sep 24, 2015-Jan 7, 2016 Mar 2016 May 2016
Financial Year 2016 – Cycle 2 Evidence-Based Cancer Prevention Services – Colorectal Cancer Prevention Coalition

This award mechanism seeks to fund projects that will deliver a comprehensive and integrated colorectal cancer screening project that includes provision of screening, diagnostic, and navigation services in conjunction with outreach and education of the target population through a coalition of partners. The proposed project should be designed to reach and serve as many people as possible by its simultaneous implementation in multiple clinical sites.

Award: No dollar limit; cost per person served must be well justified; Maximum duration of 36 months.

Sep 10, 2015 Sep 24, 2015-Jan 7, 2016 Mar 2016 May 2016

For More Information: http://www.cprit.state.tx.us/funding-opportunities#prevention